YOLFTbeta
Incyte Corporation

Incyte Corporation

INCY · NASDAQ · Healthcare / Biotechnology

120.97USD-0.73 (-0.60%)

Price History

Full chart

Market Stats

Previous Close121.70
Open121.89
Day Range119.72 – 122.07
52-Week Range84.02 – 132.60
Volume950.50K
Market Cap22.92B
P/E (TTM)14.40
Forward P/E14.71
EPS7.85
Dividend Yield0.00%
Beta0.74
50-Day Avg121.83
200-Day Avg107.50

About

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host disease. It also provides INCA033989 for the treatment of essential thrombocythemia and MF; INCA035784 for the treatment of anti-mutant calreticulin and myeloproliferative neoplasms (MPNs); INCB160058 for the treatment of MPNs; PEMAZYRE, a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ZYNYZ to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma. The company's clinical stage products include INCB123667 for ovarian cancer; INCB161734 for solid tumors; INCA33890 for cancers; Ruxolitinib cream for atopic dermatitis, hidradenitis suppurativa (HS), and prurigo nodularis; Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma; and INCB00928 for the treatment of fibrodysplasia ossificans progressive. It has collaboration and license agreement with Novartis, Lilly, and Syndax. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and distributors. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. William J. Meury
  • Employees2.84K
  • Headquarters1801 Augustine Cut-Off, Wilmington, DE, United States, 19803, USA
  • Websitehttps://www.incyte.com

Leadership

  • Mr. William J. MeuryCEO & Director · b. 1968
  • Dr. Pablo J. Cagnoni M.D., Ph.D.President and Global Head of R&D · b. 1963
  • Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & Chief Accounting Officer · b. 1978
  • Dr. Steven H. Stein M.D.Executive VP, Head of Late-stage Development & Chief Medical Officer · b. 1967
  • Mr. Mohamed Khairie IssaExecutive Vice President & Head of U.S. Commercial · b. 1983
  • Mr. Suketu P. UpadhyayExecutive VP & CFO · b. 1969
  • Mr. Michael James MorrisseyExecutive VP & Head of Global Technical Operations · b. 1964
  • Ms. Alexis SmithVP & Head of Investor Relations
  • Mr. Richard A. Hoffman J.D., M.B.A.Executive VP, General Counsel & Secretary · b. 1962
  • Ms. Pamela M. MurphyVP of Investor Relations & Corporate Communications · b. 1951

Financials

Income Statement

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue300.00K200.00K12.20M41.90M90.00M134.80M157.00M194.17M219.26M95.47M41.20M14.15M7.85M27.64M34.44M3.92M9.27M169.88M94.45M297.06M354.95M511.50M753.75M1.11B1.54B1.88B2.16B2.67B2.99B3.39B3.70B4.24B5.14B
Growth (%)--33.33%+6000.00%+243.44%+114.80%+49.78%+16.47%+23.67%+12.92%-56.46%-56.85%-65.66%-44.54%+252.32%+24.59%-88.62%+136.41%+1733.55%-44.40%+214.50%+19.49%+44.10%+47.36%+46.70%+38.93%+22.50%+14.71%+23.53%+11.98%+13.67%+8.87%+14.76%+21.22%
Cost of Revenue3.60M-900.00K-2.80M-6.50M-10.60M-17.80M-24.70M-34.84M241.88M172.32M134.57M103.02M103.05M98.00M116.30M161.31M145.54M155.11M234.73M157.00K630.00K3.00M27.00M58.19M79.48M94.12M114.25M131.30M150.99M207.00M254.99M312.10M372.10M
Gross Profit-3.30M1.10M15.00M48.40M100.60M152.60M181.70M229.01M219.26M101.61M47.09M14.15M7.85M27.64M34.44M3.92M9.27M169.88M94.45M296.90M354.32M508.49M726.75M1.05B1.46B1.79B2.04B2.54B2.84B3.19B3.44B3.93B4.77B
Gross Margin-1100.00%550.00%122.95%115.51%111.78%113.20%115.73%117.94%100.00%106.43%114.31%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%99.95%99.82%99.41%96.42%94.74%94.83%95.00%94.71%95.08%94.94%93.90%93.10%92.64%92.76%
Operating Expense1.60M13.20M25.90M57.30M97.00M140.40M208.70M291.60M283.96M234.24M196.44M163.00M108.63M104.51M119.72M163.21M149.03M155.83M237.64M295.75M370.42M513.29M676.10M902.53M1.70B1.66B1.64B2.80B2.25B2.60B2.79B3.83B3.43B
Operating Income-4.90M-12.10M-10.90M-8.90M3.60M12.20M-27.00M-62.59M-64.70M-132.63M-149.35M-148.85M-100.78M-76.86M-85.28M-159.29M-139.77M14.05M-143.18M1.15M-16.10M-4.80M50.65M145.00M-243.39M129.22M402.01M-263.68M585.78M591.63M655.36M101.29M1.34B
Operating Margin-1633.33%-6050.00%-89.34%-21.24%4.00%9.05%-17.20%-32.24%-29.51%-138.92%-362.53%-1052.26%-1284.53%-278.06%-247.62%-4064.53%-1508.56%8.27%-151.59%0.39%-4.54%-0.94%6.72%13.11%-15.84%6.87%18.62%-9.89%19.62%17.43%17.73%2.39%26.12%
EBITDA-4.50M-11.20M-8.10M-2.40M14.20M30.00M-2.30M-27.75M-17.03M-110.52M-98.50M-134.94M-92.59M-69.45M-72.32M-146.22M-123.08M35.96M-116.19M31.89M-14.99M39.69M98.04M204.57M-253.21M171.86M543.18M-178.24M630.20M599.64M919.43M408.16M1.76B
EBITDA Margin-1500.00%-5600.00%-66.39%-5.73%15.78%22.26%-1.46%-14.29%-7.77%-115.76%-239.11%-953.91%-1180.12%-251.25%-209.98%-3731.00%-1328.42%21.17%-123.01%10.74%-4.22%7.76%13.01%18.50%-16.48%9.13%25.16%-6.68%21.10%17.66%24.88%9.62%34.24%
Net Income-4.90M-11.50M-9.90M-6.80M6.90M3.50M-26.80M-29.73M-183.24M-136.88M-166.46M-164.82M-103.04M-74.17M-86.88M-178.92M-211.87M-31.85M-186.54M-44.32M-83.15M-48.48M6.53M104.22M-313.14M109.49M446.91M-295.70M948.58M340.66M597.60M32.62M1.29B
Net Income Margin-1633.33%-5750.00%-81.15%-16.23%7.67%2.60%-17.07%-15.31%-83.57%-143.38%-404.07%-1165.11%-1313.32%-268.30%-252.27%-4565.45%-2286.78%-18.75%-197.49%-14.92%-23.43%-9.48%0.87%9.43%-20.38%5.82%20.70%-11.09%31.76%10.04%16.17%0.77%25.03%
R&D--19.20M40.90M72.50M97.20M146.80M192.56M213.34M145.31M111.40M88.27M95.62M87.60M104.89M146.36M119.44M123.88M178.71M210.39M260.44M347.52M479.51M581.86M1.33B1.20B1.15B2.22B1.46B1.59B1.63B2.61B2.05B
R&D as % of Total Revenue--157.38%97.61%80.56%72.11%93.50%99.17%97.30%152.20%270.42%624.00%1218.68%316.88%304.56%3734.68%1289.17%72.92%189.20%70.82%73.37%67.94%63.62%52.62%86.32%63.66%53.46%83.10%48.83%46.72%44.04%61.46%39.88%
Interest Expense0000000009.43M7.99M17.24M16.05M17.91M24.03M24.94M32.13M43.32M43.82M46.06M38.65M47.09M45.60M38.74M6.90M1.54M1.85M2.17M1.91M2.67M2.55M2.28M2.43M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.88%19.38%121.88%204.59%64.79%69.78%636.31%346.74%25.50%46.39%15.50%10.89%9.21%6.05%3.50%0.45%0.08%0.09%0.08%0.06%0.08%0.07%0.05%0.05%

Balance Sheet

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.60M28.70M57.80M66.90M193.10M230.30M221.90M886.82M705.56M552.14M379.55M516.92M374.11M353.60M275.69M232.39M712.39M489.58M328.96M330.42M629.57M830.07M1.01B1.64B2.30B2.65B3.43B3.56B4.93B5.84B6.78B5.44B6.96B
Total Liabilities1.50M4.70M11.00M21.70M53.40M50.70M51.60M264.13M265.36M249.73M225.21M438.40M393.50M438.51M435.21M453.14M814.77M578.23M556.04M505.38M822.68M878.11M836.28M1.22B671.95M719.79M828.34M949.65M1.16B1.47B1.59B2.00B1.80B
Total Equity16.10M24.00M46.80M45.20M146.00M179.60M170.30M622.69M440.20M302.41M154.33M78.52M-19.40M-84.91M-159.52M-220.75M-102.38M-88.64M-227.08M-174.96M-193.11M-81.63M171.16M419.47M1.63B1.93B2.60B2.61B3.77B4.37B5.19B3.45B5.17B
Cash15.50M6.80M10.40M7.60M51.20M50.00M32.20M110.16M43.37M22.93M29.70M132.18M11.49M18.86M108.85M178.77M449.82M417.91M277.59M224.06M471.43M452.30M521.44M652.34M899.51M1.16B1.83B1.51B2.06B2.95B3.21B1.69B3.10B
Total Debt800.00K200.00K100.00K100.00K1.20M800.00K200.00K187.81M179.25M172.04M167.79M378.77M341.86M371.10M386.56M396.17M443.14M293.43M614.35M331.08M661.57M675.17M619.89M651.48M24.00M36.13M60.23M47.53M44.82M41.46M38.29M37.96M69.43M
Net Debt-14.70M-6.60M-10.30M-7.50M-55.60M-49.20M-32.00M77.66M135.88M149.11M138.09M246.59M330.37M352.24M277.70M217.40M-6.69M-124.48M38.56M107.02M190.14M222.87M98.45M-862.00K-875.51M-1.15B-1.78B-1.47B-2.01B-2.91B-3.18B-1.64B-3.03B

Cash Flow

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.40M-6.30M-9.00M16.00M18.70M36.20M-21.40M-7.34M-47.00M-58.27M-118.33M-114.67M-101.87M-50.37M-92.69M-140.86M12.36M97.94M-161.72M-94.83M9.18M25.99M86.54M304.76M-92.99M336.23M710.66M-124.60M749.49M969.94M496.49M335.34M1.41B
Investing Cash Flow300.00K-20.90M-20.20M-20.40M-65.40M-45.40M-8.70M-533.69M-25.56M41.23M126.35M-77.16M15.53M26.04M170.36M105.89M16.45M15.20M-2.50M-1.99M-37.40M-138.44M-105.01M-232.49M-349.98M-86.42M-87.45M-269.00M-207.70M-78.54M-207.68M157.52M-102.61M
Financing Cash Flow14.90M18.60M32.70M1.50M90.20M4.00M12.50M619.12M5.77M-3.16M-1.17M294.24M-34.35M31.70M12.32M104.88M242.25M-145.05M19.47M47.71M275.59M93.32M87.62M58.65M690.21M14.66M45.71M71.71M6.18M-794.00K-20.03M-2.02B101.04M
Capital Expenditure400.00K2.60M7.90M20.20M26.10M34.70M34.80M96.38M12.92M11.89M9.74M1.39M1.63M1.57M1.15M698.00K387.00K4.11M3.80M2.84M4.27M27.88M26.00M120.28M111.02M73.48M78.06M187.38M181.01M77.83M32.49M86.26M58.87M
Free Cash Flow-4.80M-8.90M-16.90M-4.20M-7.40M1.50M-56.20M-103.72M-59.92M-70.16M-128.07M-116.06M-103.50M-51.94M-93.85M-141.56M11.97M93.83M-165.51M-97.67M4.91M-1.89M60.53M184.48M-204.01M262.74M632.59M-311.98M568.48M892.11M464.00M249.07M1.35B
Dividends Paid------------------0000000-16.75M22.76M29.94M26.30M---
FCF to OCF109.09%141.27%187.78%-26.25%-39.57%4.14%262.62%1412.31%127.48%120.41%108.23%101.21%101.60%103.11%101.24%100.50%96.87%95.80%102.35%102.99%53.52%-7.25%69.95%60.53%219.39%78.14%89.02%250.39%75.85%91.98%93.46%74.28%95.84%
Dividend Paid to FCF------------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%-2.65%-7.30%5.27%2.95%---

Earnings

Report DateOct 25, 1995Feb 21, 1996Apr 25, 1996Jul 25, 1996Oct 24, 1996Feb 26, 1997Apr 17, 1997Jul 15, 1997Oct 15, 1997Jan 13, 1998Apr 8, 1998Jul 14, 1998Oct 14, 1998Feb 3, 1999Apr 21, 1999Jul 14, 1999Oct 19, 1999Jan 26, 2000Apr 19, 2000Jul 18, 2000Oct 17, 2000Feb 1, 2001Apr 25, 2001Jul 19, 2001Oct 25, 2001Feb 13, 2002Apr 30, 2002Jul 25, 2002Nov 12, 2002Feb 19, 2003May 5, 2003Jul 30, 2003Nov 4, 2003Feb 2, 2004May 4, 2004Aug 4, 2004Nov 4, 2004Feb 28, 2005May 4, 2005Aug 1, 2005Nov 1, 2005Feb 16, 2006May 4, 2006Jul 27, 2006Nov 2, 2006Feb 15, 2007May 3, 2007Jul 26, 2007Nov 1, 2007Feb 14, 2008Apr 30, 2008Jul 29, 2008Nov 6, 2008Feb 18, 2009May 7, 2009Jul 30, 2009Nov 5, 2009Feb 18, 2010May 6, 2010Aug 5, 2010Nov 9, 2010Feb 10, 2011May 3, 2011Jul 28, 2011Oct 27, 2011Feb 15, 2012Apr 26, 2012Aug 2, 2012Nov 1, 2012Feb 14, 2013May 2, 2013Aug 1, 2013Oct 31, 2013Feb 12, 2014May 1, 2014Jul 31, 2014Oct 30, 2014Feb 12, 2015Apr 30, 2015Aug 4, 2015Nov 3, 2015Feb 11, 2016May 9, 2016Aug 9, 2016Nov 1, 2016Feb 14, 2017May 4, 2017Aug 1, 2017Oct 31, 2017Feb 15, 2018May 1, 2018Jul 31, 2018Oct 30, 2018Feb 14, 2019Apr 30, 2019Jul 30, 2019Oct 29, 2019Feb 13, 2020May 5, 2020Aug 4, 2020Nov 5, 2020Feb 9, 2021May 4, 2021Aug 3, 2021Nov 2, 2021Feb 8, 2022May 3, 2022Aug 2, 2022Nov 1, 2022Feb 7, 2023May 2, 2023Aug 1, 2023Oct 31, 2023Feb 13, 2024Apr 30, 2024Jul 30, 2024Oct 29, 2024Feb 10, 2025Apr 29, 2025Jul 29, 2025Oct 28, 2025Feb 10, 2026Apr 28, 2026Jul 28, 2026Oct 27, 2026Oct 29, 2026
EPS Estimate-0.06-0.06-0.04-0.03-0.010.010.030.040.060.070.080.090.100.10-0.08-0.11-0.19-0.12-0.28-0.22-0.12-0.12-0.28-0.23-0.19-0.76-0.21-0.28-0.37-0.39-0.28-0.39-0.39-0.43-0.48-0.39-0.42-0.35-0.33-0.33-0.38-0.31-0.25-0.24-0.24-0.25-0.26-0.27-0.27-0.28-0.47-0.50-0.50-0.48-0.42-0.42-0.41-0.36-0.32-0.02-0.310.19-0.31-0.35-0.44-0.39-0.48-0.01-0.20-0.02-0.180.01-0.12-0.13-0.19-0.12-0.07-0.16-0.07-0.09-0.420.170.27-0.030.020.14-0.88-0.040.06-0.450.120.220.410.460.410.500.640.58-2.800.860.760.770.640.740.760.870.690.750.710.570.740.871.071.150.831.111.091.551.031.471.641.921.341.76-3.58-3.87
EPS Actual-0.09-0.06-0.04-0.040.000.010.020.040.060.090.080.100.080.12-0.04-0.11-0.19-0.11-0.13-0.10-0.12-0.11-0.16-0.15-0.09-0.22-0.20-0.26-0.45-0.45-0.36-0.37-0.32-0.34-0.38-0.40-0.32-0.47-0.24-0.34-0.36-0.33-0.24-0.19-0.19-0.24-0.26-0.22-0.29-0.26-0.47-0.54-0.48-0.50-0.41-0.41-0.39-0.41-0.300.02-0.260.24-0.21-0.41-0.42-0.44-0.360.03-0.170.14-0.120.05-0.14-0.15-0.20-0.220.33-0.22-0.11-0.10-0.220.290.120.180.190.05-0.96-0.060.17-0.71-0.010.260.380.400.620.750.820.65-2.861.240.230.930.670.801.180.100.551.010.600.620.370.991.101.060.64-1.821.071.431.161.572.261.801.812.80--
Surprise-50.00%0.00%0.00%-33.33%100.00%0.00%-33.33%0.00%0.00%28.57%0.00%11.11%-20.00%20.00%50.00%0.00%0.00%8.33%53.57%54.55%0.00%8.33%42.86%34.78%52.63%71.05%4.76%7.14%-21.62%-15.38%-28.57%5.13%17.95%20.93%20.83%-2.56%23.81%-34.29%27.27%-3.03%5.26%-6.45%4.00%20.83%20.83%4.00%0.00%18.52%-7.41%7.14%0.00%-8.00%4.00%-4.17%2.38%2.38%4.88%-13.89%6.25%200.00%16.13%26.32%32.26%-17.14%4.55%-12.82%25.00%400.00%15.00%800.00%33.33%400.00%-16.67%-15.38%-5.26%-83.33%571.43%-37.50%-57.14%-11.11%47.62%70.59%-55.56%700.00%850.00%-64.29%-9.09%-50.00%183.33%-57.78%-108.33%18.18%-7.32%-13.04%51.22%50.00%28.13%12.07%-2.14%44.19%-69.74%20.78%4.69%8.11%55.26%-88.51%-20.29%34.67%-15.49%8.77%-50.00%13.79%2.80%-7.83%-22.89%-263.96%-1.83%-7.74%12.62%6.80%37.80%-6.25%35.07%59.09%--
Timing-------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----------Pre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap22.92B
Enterprise Value21.23B
Trailing P/E14.40
Forward P/E14.71
PEG Ratio10.82
Price / Sales3.94
Price / Book4.05
EPS7.85
Book Value31.57
Revenue (TTM)5.82B
Gross Profit (TTM)3.24B
EBITDA1.94B
Profit Margin27.71%
Operating Margin41.90%
Return on Equity30.67%
Return on Assets16.83%
Shares Outstanding202.70M
Shares Float170.41M
Beta0.74
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 28 analystsTarget 129.50
  • Strong Buy
    10
  • Buy
    2
  • Hold
    15
  • Sell
    1

Ownership Breakdown

Institutions
103.59%
Insiders
1.85%
Retail / Other
0.00%

Top Institutional Holders

  • Baker Bros Advisors LP
    30.76M15.18%
  • BlackRock Inc
    18.03M8.90%
  • Dodge & Cox
    11.96M5.90%
  • Vanguard Capital Management, LLC
    11.02M5.44%
  • State Street Corp
    9.72M4.80%
  • Vanguard Portfolio Management, LLC
    7.79M3.84%
  • AQR Capital Management LLC
    5.32M2.63%
  • Geode Capital Management, LLC
    4.75M2.34%
  • LSV Asset Management
    4.12M2.03%
  • Amvescap Plc.
    4.08M2.01%
  • Wellington Management Company LLP
    3.58M1.76%
  • Renaissance Technologies Corp
    3.51M1.73%
  • Morgan Stanley - Brokerage Accounts
    2.95M1.45%
  • Arrowstreet Capital Limited Partnership
    2.74M1.35%
  • Robeco Institutional Asset Management BV
    2.44M1.20%

Top Fund Holders

  • Dodge & Cox Stock I
    7.95M3.92%
  • Vanguard MStar Total Stk Mkt Idx Invest
    5.40M2.66%
  • Vanguard 500 Index Investor
    4.47M2.21%
  • Vanguard Small Cap Index
    3.88M1.91%
  • Vanguard Health Care Inv
    2.55M1.26%

Stock Splits

  • Sep 1, 20002:1
  • Nov 10, 19972:1